news aktuell GmbH

SAFENet Expands: New members join European router and network technology alliance / Five companies from four countries join the alliance for Europe's technological sovereignty

10.9.2026 12:00:00 CEST | news aktuell GmbH | Press Release

Share

Berlin, 10 September 2026 – The Sovereignty Alliance for European Network Technology (SAFENet) welcomes five new members: Genexis, IPmotion, MB connect line, Teldat and Waystream. The alliance is growing rapidly, expanding from four to nine European network technology companies just a few weeks after its founding. With this growth, the alliance significantly broadens its European base. Their shared goal: to strengthen Europe's technological capacity to act – and to ensure that European network technology is given the weight it deserves in Brussels and in national capitals.

The new members bring a range of complementary strengths across network infrastructure:

  • Genexis (Netherlands/Sweden): The broadband specialist offers fibre termination and home networking solutions – from ONTs and residential gateways to extenders and management software.
  • IPmotion (Germany): The manufacturer develops mobile internet access and router solutions for rail and road transport, public safety and other mobile applications.
  • MB connect line (Germany): The manufacturer develops secure remote access solutions, industrial routers and OT security gateways for machine builders and industrial operators. Its portfolio enables the secure connection, remote maintenance and segmentation of machines, systems and industrial networks, including protected network transitions between OT environments.
  • Teldat (Spain): The provider develops router, SD-WAN, 5G and cybersecurity solutions for businesses, public institutions and critical infrastructure.
  • Waystream (Sweden): The company develops access switches and routers for the fibre networks of municipal networks and network operators in Northern and Central Europe.

Read the full release here: safe-net.tech/news

About SAFENet

The Sovereignty Alliance for European Network Technology (SAFENet) is a strategic alliance of leading European network technology companies. Its goal: a digital Europe that is self-determined, resilient and future proof. safe-net.tech.

Contacts

Kira Terstappen-Richter · SAFENet · media@safe-net.tech

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release

New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release

Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye